sb 203580 has been researched along with myristic acid in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (myristic acid) | Trials (myristic acid) | Recent Studies (post-2010) (myristic acid) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 1,727 | 24 | 409 |
| Protein | Taxonomy | sb 203580 (IC50) | myristic acid (IC50) |
|---|---|---|---|
| Toll-like receptor 2 | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ensign, WY; Han, J; Jiang, B; Li, Y; Vogt, PK | 1 |
1 other study(ies) available for sb 203580 and myristic acid
| Article | Year |
|---|---|
Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; Cell Line; Chromones; Enzyme Activation; Enzyme Inhibitors; Genes, Reporter; Humans; Imidazoles; Isoenzymes; MAP Kinase Kinase 6; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Models, Biological; Morpholines; Muscles; Mutation; MyoD Protein; Myristic Acid; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyridines; Transcription, Genetic; Transfection | 2000 |